Katherine Thiel
Hematology & Oncology · Jackson, MSNPI 1134702780
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in MS, where the typical reported total is $9,632.
Across 112 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$302
- Novartis$172
- Bristol Myers Squibb$161
- Merck$144
- Incyte Corporation$128
- Johnson & Johnson$126
- plus $1K from 35 others
What the payments were for
- Food & beverage$2,29198%
- Education$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $302 |
| Novartis | 10 | $172 |
| Bristol Myers Squibb | 7 | $161 |
| Merck | 7 | $144 |
| Incyte Corporation | 5 | $128 |
| Johnson & Johnson | 6 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Sobi, Inc | 3 | $73 |
| Taiho Oncology, Inc. | 3 | $72 |
| Novo Nordisk | 3 | $66 |
| Stemline Therapeutics Inc. | 3 | $66 |
| Alnylam Pharmaceuticals Inc. | 4 | $64 |
| Genentech USA, Inc. | 3 | $62 |
| Astellas Pharma US Inc | 3 | $60 |
| Karyopharm Therapeutics Inc. | 3 | $53 |
| Daiichi Sankyo Inc. | 2 | $50 |
| AVEO Pharmaceuticals, Inc. | 2 | $43 |
| Agios Pharmaceuticals, Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| Pfizer | 2 | $39 |
| GSK | 2 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| AbbVie | 1 | $31 |
| Geron Corporation | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Pharmaessentia USA Corporation | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Exelixis Inc. | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $20 |
| Invivyd Inc | 1 | $19 |
| Kedrion Biopharma, Inc. | 1 | $19 |
| Emmaus Medical, Inc. | 1 | $18 |
| Gilead | 1 | $18 |
| Array Biopharma Inc | 1 | $17 |
| Sanofi | 1 | $16 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| Genmab U.S., Inc. | 1 | $16 |
How this compares
$2,341 in reported general payments places this provider in the 15th percentile of 57 hematology & oncology providers in Mississippi.
Other hematology & oncology in Jackson
- Carter MilnerJackson$248K
- Guangzhi QuJackson$59K
- John HeneganJackson$35K
- Barbara CraftJackson$11K
- Grace ShumakerJackson$7K
- Justin BakerJackson$3K
- Bobby WilkersonJackson$2K
- Solly ChedidPascagoula$1.7M
- Jennifer EubanksMeridian$44K
- Daniel PattersonPascagoula$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.